01 BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE (1)
01 CASPER PHARMA LLC (1)
01 TABLET, CHEWABLE, TABLET, CAPSULE;ORAL (1)
01 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (1)
19
DELCOR ASSET, based in U.S.A, is a pharmaceutical company.
One of their notable products is BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE, with a corresponding application number 50719 and regulatory information .
proudly manufactured in the
approval since 1996-08-15
DELCOR ASSET's HELIDAC TABLET, CHEWABLE, TABLET, CAPSULE;ORAL, medication with 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE.